Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Is Ocugen About to Beat Moderna in This One Market?
Is Ocugen About to Beat Moderna in This One Market?
Is Ocugen About to Beat Moderna in This One Market?
Submitted by
admin
on November 12, 2021 - 10:35am
Source:
Motley Fool
News Tags:
Moderna Therapeutics
Ocugen
vaccines
Covaxin
COVID-19
pediatric
Headline:
Is Ocugen About to Beat Moderna in This One Market?
snippet:
Ocugen is taking longer than expected to bring its vaccine candidate Covaxin to the U.S. adult market.
The company will apply for approval instead of emergency authorization.
Ocugen surprised investors recently when it applied for authorization in a specific population.
Do Not Allow Advertisers to Use My Personal information